Two new graphics from Diabetes UK’s COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.

LEAVE A REPLY

Please enter your comment!
Please enter your name here